Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Contrary to prior case reports that described occasional clinical failures with cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infections, recent studies have demonstrated no difference in outcomes between cefazolin and antistaphylococcal penicillins for the treatment of MSSA bacteremia. While promising, these studies described low frequencies of high-inoculum infections, such as endocarditis. This retrospective study compares clinical outcomes of cefazolin versus oxacillin for complicated MSSA bacteremia at two tertiary care hospitals between January 2008 and June 2012. Fifty-nine patients treated with cefazolin and 34 patients treated with oxacillin were included. Osteoarticular (41%) and endovascular (20%) sources were the predominant sites of infection. The rates of clinical cure at the end of therapy were similar between cefazolin and oxacillin (95% versus 88%; P = 0.25), but overall failure at 90 days was higher in the oxacillin arm (47% versus 24%; P = 0.04). Failures were more likely to have received surgical interventions (63% versus 40%; P = 0.05) and to have an osteoarticular source (57% versus 33%; P = 0.04). Failures also had a longer duration of bacteremia (7 versus 3 days; P = 0.0002), which was the only predictor of failure. Antibiotic selection was not predictive of failure. Rates of adverse drug events were higher in the oxacillin arm (30% versus 3%; P = 0.0006), and oxacillin was more frequently discontinued due to adverse drug events (21% versus 3%; P = 0.01). Cefazolin appears similar to oxacillin for the treatment of complicated MSSA bacteremia but with significantly improved safety. The higher rates of failure with oxacillin may have been confounded by other patient factors and warrant further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420939 · Cited by 532
Paul, M., Zemer-Wassercug, N., Talker, O., Lishtzinsky, Y., Lev, B., Samra, Z., Leibovici, L., & Bishara, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03425.x · Cited by 188
Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome
Khatib, R., Johnson, L. B., Fakih, M. G., Riederer, K., Khosrovaneh, A., Shamse Tabriz, M., Sharma, M., & Saeed, S. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500372846 · Cited by 168
Hawkins, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.17.1861 · Cited by 166
Nannini, E. C., Stryjewski, M. E., Singh, K. V., Bourgogne, A., Rude, T. H., Corey, G. R., Fowler, V. G., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-09 · Cited by 160
Lee, S., Choe, P. G., Song, K.-H., Park, S.-W., Kim, H. B., Kim, N. J., Kim, E.-C., Park, W. B., & Oh, M.-D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00485-11 · Cited by 128
Chong, Y. P., Park, S., Kim, H. S., Kim, E. S., Kim, M., Park, K., Kim, S., Lee, S., Choi, S., Jeong, J., et al. (2013) · Medicine · doi:10.1097/md.0b013e318289ff1e · Cited by 126
Research works printed but not linked: 5
- Echevarria K, Childs L, Oates E, Cadena J. 2012. Antibiotic stewardship involving anti-staphylococcal beta-lactams at a Veterans Affairs hospital. Abstr. IDWeek 2012, abstr 34750. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Abstr.%20IDWeek%202012,%20abstr%2034750&title=Antibiotic%20stewardship%20involving%20anti-staphylococcal%20beta-lactams%20at%20a%20Veterans%20Affairs%20hospital&author=K%20Echevarria&author=L%20Childs&author=E%20Oates&author=J%20Cadena&publication_year=2012&)]
- Lewis JS, II, Bowling JE, Laurel Y, Jorgensen JH. 2012. Clinical and financial impact of the replacement of oxacillin with cefazolin for MSSA infections. Abstr. IDWeek 2012, abstr 739. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Abstr.%20IDWeek%202012,%20abstr%20739&title=Clinical%20and%20financial%20impact%20of%20the%20replacement%20of%20oxacillin%20with%20cefazolin%20for%20MSSA%20infections&author=JS%20Lewis&author=JE%20Bowling&author=Y%20Laurel&author=JH%20Jorgensen&publication_year=2012&)]
- Nevrekar S, Rhodes N, Crank C, Scheetz MH, Pavell A, Segreti J, Wang S. 2013. Treatment outcomes of cefazolin versus oxacillin for high burden methicillin-sensitive Staphylococcus aureus (MSSA) bloodstream infections (BSI). Abstr. IDWeek 2013, abstr 1731. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Abstr.%20IDWeek%202013,%20abstr%201731&title=Treatment%20outcomes%20of%20cefazolin%20versus%20oxacillin%20for%20high%20burden%20methicillin-sensitive%20Staphylococcus%20aureus%20(MSSA)%20bloodstream%20infections%20(BSI)&author=S%20Nevrekar&author=N%20Rhodes&author=C%20Crank&author=MH%20Scheetz&author=A%20Pavell&publication_year=2013&)]
- Huang M, Knepper B, Haas M, Jenkins T. 2013. Effects of an intervention to substitute cefazolin for nafcillin in selected cases of methicillin-susceptible Staphylococcus aureus bacteremia. Abstr. IDWeek 2013, abstr 1017. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Abstr.%20IDWeek%202013,%20abstr%201017&title=Effects%20of%20an%20intervention%20to%20substitute%20cefazolin%20for%20nafcillin%20in%20selected%20cases%20of%20methicillin-susceptible%20Staphylococcus%20aureus%20bacteremia&author=M%20Huang&author=B%20Knepper&author=M%20Haas&author=T%20Jenkins&publication_year=2013&)]
- Nuibe A, Olson J, Hersh A, Stockmann C, Sanderson S, Pavia A, Thorell EA. 2013. Costs and outcomes for children with methicillin-susceptible Staphylococcus aureus osteoarticular infections with bacteremia. Abstr. IDWeek 2013, abstr 421. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Abstr.%20IDWeek%202013,%20abstr%20421&title=Costs%20and%20outcomes%20for%20children%20with%20methicillin-susceptible%20Staphylococcus%20aureus%20osteoarticular%20infections%20with%20bacteremia&author=A%20Nuibe&author=J%20Olson&author=A%20Hersh&author=C%20Stockmann&author=S%20Sanderson&publication_year=2013&)]
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Chaves, F., Garnacho-Montero, J., del Pozo, J. L., Bouza, E., Capdevila, J. A., de Cueto, M., Domínguez, M. Á., Esteban, J., Fernández-Hidalgo, N., Fernández Sampedro, M., et al. (2018) · Medicina Intensiva · doi:10.1016/j.medin.2017.09.012 · Cited by 170
McDanel, J. S., Roghmann, M., Perencevich, E. N., Ohl, M., Goto, M., Livorsi, D. J., Jones, M., Albertson, J., Nair, R., O’Shea, A. M. J., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix287 · Cited by 157
Weis, S., Kesselmeier, M., Davis, J. S., Morris, A. M., Lee, S., Scherag, A., Hagel, S., & Pletz, M. W. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.010 · Cited by 129
Miller, W. R., Seas, C., Carvajal, L. P., Díaz, L., Echeverri, A. M., Ferro, C., Ríos, R., Porras, P., Luna, C. M., Gotuzzo, E., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy123 · Cited by 116
Sunderkötter, C. H., Becker, K., Eckmann, C., Graninger, W., Kujath, P., & Schöfer, H. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13790_g · Cited by 98
Rao, S. N., Rhodes, N. J., Lee, B. J., Scheetz, M. H., Hanson, A. P., Segreti, J., Crank, C. W., & Wang, S. K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04677-14 · Cited by 87
Lee, S., Song, K., Jung, S., Park, W. B., Lee, S. H., Ys, K., Kwak, Y. G., Kim, Y. K., Kiem, S., Kim, H.-I., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.001 · Cited by 85
Bai, A. D., Showler, A., Burry, L. D., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M. E., Fernando, E., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku560 · Cited by 82
Loubet, P., Burdet, C., Vindrios, W., Grall, N., Wolff, M., Yazdanpanah, Y., Andremont, A., Duval, X., & Lescure, F.-X. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.003 · Cited by 69
Shi, C., Xiao, Y., Zhang, Q., Li, Q., Wang, F., Wu, J., & Lin, N. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3418-9 · Cited by 63
Wildenthal, J. A., Atkinson, A., Lewis, S. K., Sayood, S. J., Nolan, N. S., Cabrera, N. L., Marschall, J., Durkin, M. J., & Marks, L. R. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac714 · Cited by 61
Ulloa, E. R., Singh, K. V., Geriak, M., Haddad, F. A., Murray, B. E., Nizet, V., & Sakoulas, G. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz995 · Cited by 63
Eljaaly, K., Alshehri, S. O., & Erstad, B. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01816-17 · Cited by 59
Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management
McNeil, J. C. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s257517 · Cited by 59
Sakoulas, G., Olson, J., Yim, J., Singh, N. B., Kumaraswamy, M., Quach, D., Rybak, M. J., Pogliano, J., & Nizet, V. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01192-16 · Cited by 61
Bidell, M. R., Patel, N., & O’Donnell, J. N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky259 · Cited by 57
Lee, B., Tam, I., Weigel, B., Breeze, J. L., Paulus, J. K., Nelson, J., & Allison, G. M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv130 · Cited by 58
Li, J., Echevarria, K. L., & Traugott, K. A. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1892 · Cited by 52
Self-citationAustin, E. D., Sullivan, S. S., Maćešić, N., Mehta, M., Miko, B. A., Nematollahi, S., Shi, Q., Lowy, F. D., & Uhlemann, A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz498 · Cited by 52
Advances in the therapy of bacterial bloodstream infections
Giannella, M., Bartoletti, M., Gatti, M., & Viale, P. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.001 · Cited by 52
Pollett, S., Baxi, S. M., Rutherford, G. W., Doernberg, S. B., Bacchetti, P., & Chambers, H. F. “. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00243-16 · Cited by 51
Yadav, R., Bulitta, J. B., Nation, R. L., & Landersdorfer, C. B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-16 · Cited by 49
Sunderkötter, C. H., Becker, K., Eckmann, C., Graninger, W., Kujath, P., & Schöfer, H. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13790 · Cited by 57
Wang, S. K., Gilchrist, A., Loukitcheva, A., Plotkin, B. J., Sigar, I. M., Gross, A. E., O’Donnell, J. N., Pettit, N. N., Buros, A. F., O’Driscoll, T., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00382-18 · Cited by 45
Beganovic, M., Cusumano, J. A., Lopes, V., LaPlante, K. L., & Caffrey, A. R. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz270 · Cited by 44
Truong, J. Q., Veillette, J. J., & Forland, S. C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01554-17 · Cited by 43
Sakoulas, G., Geriak, M., & Nizet, V. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy557 · Cited by 46
A review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 44
Rindone, J. P., & Mellen, C. K. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13554 · Cited by 40
Burdet, C., Saïdani, N., Dupieux, C., Lemaignen, A., Canouï, É., Surgers, L., Vareil, M.-O., Lefort, A., Lepeule, R., Peiffer‐Smadja, N., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01624-1 · Cited by 38
McNeil, J. C., Sommer, L. M., Boyle, M., Hogan, P. G., Vallejo, J. G., Hultén, K. G., Flores, A. R., Kaplan, S. L., & Fritz, S. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00703-20 · Cited by 37
the Korea INfectious Diseases (KIND) study group, Song, K., Jung, S., Lee, S., Park, S., Kiem, S., Lee, S. H., Kwak, Y.-G., Ys, K., Jang, H.-C., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2799-1 · Cited by 35
Hale, C. M., Steele, J. M., Seabury, R. W., & Miller, C. D. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190016688771 · Cited by 36
Holmes, N. E., Robinson, J. O., van Hal, S. J., Munckhof, W., Athan, E., Korman, T. M., Cheng, A. C., Turnidge, J. D., Johnson, P. D. R., & Howden, B. P. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3011-2 · Cited by 37
Davis, J. S., Turnidge, J. D., & Tong, S. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.013 · Cited by 34
Monogue, M. L., Ortwine, J. K., Wei, W., Eljaaly, K., & Bhavan, K. (2018) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2018.02.004 · Cited by 33
Carr, D. R., Stiefel, U., Bonomo, R. A., Burant, C. J., & Sims, S. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy089 · Cited by 31
Carvajal, L. P., Rincón, S., Echeverri, A. M., Porras, J., Ríos, R., Ordóñez, K., Seas, C., Gomez-Villegas, S. I., Díaz, L., Arias, C. A., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02511-19 · Cited by 30
Lecomte, R., Bourreau, A., Deschanvres, C., Issa, N., Turnier, P. L., Gaborit, B. J., Chauveau, M., Leroy, A., Tourneau, T. L., Caillon, J., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.044 · Cited by 32
Prosty, C. J., Noutsios, C. D., Lee, T. C., Daneman, N., Davis, J. S., Jager, N. G. L., Ghanem‐Zoubi, N., Goodman, A. L., Kaasch, A. J., Kouijzer, I. J. E., et al. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.04.045 · Cited by 31
Allen, J. M., Bakare, L. S., Casapao, A. M., Klinker, K. P., Childs‐Kean, L. M., & Pomputius, A. F. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00259-4 · Cited by 29
Miller, M. A., Fish, D. N., Barber, G. R., Barron, M. A., Goolsby, T. A., Moine, P., & Mueller, S. W. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.07.006 · Cited by 28
Safety of Outpatient Parenteral Antimicrobial Therapy in Children
Fernandes, P., Milliren, C. E., Mahoney-West, H., Schwartz, L., Lachenauer, C. S., & Nakamura, M. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001716 · Cited by 29
Wi, Y. M., Park, Y. K., Moon, C., Ryu, S. Y., Lee, H., Ki, H. K., Cheong, H. S., Son, J. S., Lee, J. S., Kwon, K. T., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.07.011 · Cited by 29
Viehman, J. A., Oleksiuk, L., Sheridan, K. R., Byers, K. E., He, P., Falcione, B. A., & Shields, R. K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03122-15 · Cited by 26
Significant publications on infectious diseases pharmacotherapy in 2015
Babic, J. T., Sofjan, A. K., Babin, M., Echevarria, K. L., Ikwuagwu, J. O., Lam, W.-Y. M., Aitken, S. L., & Perez, K. K. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160090 · Cited by 26
Self-citationInfluence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia
Turner, N., Moehring, R. W., Sarubbi, C., Wrenn, R., Drew, R. H., Cunningham, C. K., Fowler, V. G., & Anderson, D. J. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy042 · Cited by 26
Lefèvre, B., Hoen, B., Goehringer, F., Sime, W. N., Aissa, N., Alauzet, C., Jeanmaire, E., Hénard, S., Filippetti, L., Selton‐Suty, C., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04313-3 · Cited by 23
Bourreau, A., Mabecque, V. L., Broquet, A. H., & Caillon, J. (2022) · Infectious Diseases Now · doi:10.1016/j.idnow.2022.09.021 · Cited by 23
Burdet, C., Loubet, P., Moing, V. L., Vindrios, W., Esposito‐Farèse, M., Linard, M., Ferry, T., Massias, L., Tattevin, P., Wolff, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023151 · Cited by 25
El-Dalati, S. A., Sridaran, S., Uricchio, M. N., Kline, E. G., & Shields, R. K. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab148 · Cited by 22
Antosz, K., Battle, S., Chang, J. H. T., Scheetz, M. H., Al‐Hasan, M. N., & Bookstaver, P. B. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2750 · Cited by 22
Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Haut- und Weichgewebeinfektionen
Sunderkötter, C. H., Becker, K., Eckmann, C., Graninger, W., Kujath, P., & Schöfer, H. (2020) · GMS infectious diseases · doi:10.3205/id000055 · Cited by 26
Campioli, C. C., Go, J. R., Saleh, O. A., Challener, D. W., Yetmar, Z. A., & Osmon, D. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab071 · Cited by 20
Lee, B. J., Wang, S. K., Constantino-Corpuz, J. K., Apolinario, K., Nadler, B., McDanel, J. S., Scheetz, M. H., & Rhodes, N. J. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.013 · Cited by 20
Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019*
Yavuz, S. Ş., Akar, A. R., Aydoğdu, S., Deniz, D. B., Demir, H., Hazırolan, T., Ozatik, M. A., Özer, N., Sargın, M., Topçuoğlu, N., et al. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.89689 · Cited by 25
Shah, M. D., Wardlow, L. C., Stevenson, K., Coe, K. E., & Reed, E. E. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2124 · Cited by 17
Aldman, M. H., Kavyani, R., Kahn, F., & Påhlman, L. I. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106567 · Cited by 17
Giacobbe, D. R., Dettori, S., Corcione, S., Vena, A., Sepulcri, C., Maraolo, A. E., Rosa, F. G. D., & Bassetti, M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s318322 · Cited by 17
Acute kidney injury in Staphylococcus aureus bacteraemia: a recurrent events analysis
Buis, D. T. P., van der Vaart, T. W., Mohan, A., Prins, J. M., van der Meer, J. T. M., Bonten, M. J. M., Jakulj, L., van Werkhoven, C. H., & Sigaloff, K. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.06.017 · Cited by 16
Gatti, M., Viaggi, B., Rossolini, G. M., Pea, F., & Viale, P. (2023) · Microorganisms · doi:10.3390/microorganisms11020394 · Cited by 17
Lee, S. H., Park, W. B., Lee, S., Park, S., Kim, S., Lee, J., Chang, H., Kwon, K. T., Choe, P. G., Kim, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01517-16 · Cited by 15
Lam, P. W., Graham, C., Leis, J. A., & Daneman, N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00900-18 · Cited by 14
‘Lost in Nasal Space’: Staphylococcus aureus sepsis associated with Nasal Handkerchief Packing
Koehler, P. A., Jung, N., Kochanek, M., Lohneis, P., Shimabukuro‐Vornhagen, A., & Böll, B. (2018) · Infection · doi:10.1007/s15010-018-1221-6 · Cited by 14
Timbrook, T. T., McKay, L., Sutton, J. D., & Spivak, E. S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01818-19 · Cited by 14
Bai, A. D., Findlater, A. R., Irfan, N., Singhal, N., & Loeb, M. B. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106429 · Cited by 11
Frisby, J., Ali, N., Niemotka, S. L., & Abate, G. (2023) · Antibiotics · doi:10.3390/antibiotics12020330 · Cited by 11
Burrelli, C. C., Broadbent, E. K., Margulis, A., Snyder, G. M., Gold, H. S., McCoy, C. P., Mahoney, M. V. G., & Hirsch, E. B. (2018) · Chemotherapy · doi:10.1159/000499033 · Cited by 11
Staphylococcus lugdunensisbacteremia and endocarditis treated with cefazolin and rifampin
Duhon, B. M., Dallas, S. D., Velasquez, S. A. T., & Hand, E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140498 · Cited by 10
Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin
Strazzulla, A., Chakvetadze, C., Picque, M., Cassard, B., Hernandez, F., de Pontfarcy, A., Flateau, C., Danneels, P., Belfeki, N., & Diamantis, S. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3412-6 · Cited by 10
Yavuz, S. Ş., Akar, A., Aydoğdu, S., Berzeg-Deniz, D., Demir, H., Hazırolan, T., Özatık, M. A., Özer, N., Sarğın, M., Topçuoğlu, N., et al. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 13
Mohamed, A., Bennett, N. T., Ploetz, J., Aragon, L., Kennedy, K. F., & Boyd, S. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106632 · Cited by 9
Lother, S., & Press, N. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0599-0 · Cited by 11
Campbell, P. O., Chin, P. K. L., Dalton, S. C., Metcalf, S. C. L., Douglas, N. M., & Chambers, S. T. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106695 · Cited by 10
Karchmer, A. W. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix288 · Cited by 9
Cháves, F., Garnacho‐Montero, J., del Pozo, J. L., Bouza, E., Capdevila, J. A., de Cueto, M., Domínguez, M. Á., Esteban, J., Fernández‐Hidalgo, N., Sampedro, M. F., et al. (2018) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2017.09.001 · Cited by 15
Card, K. J., Crozier, D., Durmaz, A., Gray, J., Creary, J., Stocks, A., Maltas, J., Bonomo, R. A., Burke, Z. D. C., & Scott, J. G. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507962122 · Cited by 10
Whitenack, K., Ilges, D., Epps, K. L., McGary, A. K., & Robinson, J. C. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251313874 · Cited by 8
Lee, B. J., Rao, S. N., Wang, S. K., Lee, J. Y., Lakada, I. Y., Gilbert, E. M., Barr, V. O., Postelnick, M. J., Sutton, S. H., Zembower, T., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.12.021 · Cited by 8
Pliakos, E. E., Ziakas, P. D., & Mylonakis, E. E. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab476 · Cited by 8
Suspected allergy to Beta-Lactam antibiotics: An infectiological perspective
Sunderkötter, C. (2022) · Allergologie select · doi:10.5414/alx02314e · Cited by 8
Chan, L., Chan-Tompkins, N. H., Como, J., & Guarascio, A. J. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019897267 · Cited by 7
Barber, K. E., Cramer, R. A., Bell, A. M., Wagner, J. L., & Stover, K. R. (2021) · Case Reports in Infectious Diseases · doi:10.1155/2021/8884685 · Cited by 6
Significant Publications on Infectious Diseases Pharmacotherapy in 2021
Nguyen, N. T. H., Chua, H. C., Drake, T. C., Jo, J., Stramel, S., Vuong, N. N., Gonzales-Luna, A. J., Olson, K., & on behalf of the Houston Infectious Diseases Network (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221128334 · Cited by 5
Wood, J. B., Newland, J. G., Thomsen, I. P., & Creech, C. B. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piw052 · Cited by 5
Bacteriemia: revisión narrativa de la literatura
Serpa, O. V. V., Pájaro-Galvis, N., Pastrana, K. L. R., Garzón, D. L. B., Geney, S. I. T., Pastrana, G. L. R., Fernández, B. T., Suazman, B. D. D., Gaviria, F. M., & Rico-Fontalvo, J. E. (2022) · Boletín de la Sociedad Peruana de Medicina Interna/Revista de la Sociedad Peruana de Medicina Interna · doi:10.36393/spmi.v35i2.670 · Cited by 4
Khoury, A., & Rattanasuwan, T. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.endocarditis_overview · Cited by 4
Khokhar, A., Batko, B. D., Hanna, G., Cleary, C., Rousseau, M. A., Crawford, L. M., & Edobor‐Osula, F. (2023) · Journal of Pediatric Orthopaedics B · doi:10.1097/bpb.0000000000001126 · Cited by 3
Gras, E., Tran, Y., Kably, B., Louët, A. L., Caruba, T., Sabatier, B., Launay, M., Billaud, E. M., Smadja, D. M., Gendron, N., et al. (2023) · Infection · doi:10.1007/s15010-023-02145-1 · Cited by 3
Quiñonez-Flores, A., Martínez-Guerra, B. A., Román-Montes, C. M., Tamez-Torres, K. M., González-Lara, M. F., Ponce‐de‐León, A., & Rajme‐López, S. (2024) · Antibiotics · doi:10.3390/antibiotics13020176 · Cited by 3
Yilmaz, C., Çelik, Ç., Ildız, N., EREN, E. E., Dündar, M. A., Kayabaş, Ü., & Öçsoy, İ. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007052 · Cited by 3
Sales, M. J., Sakoulas, G., Szubin, R., Palsson, B. Ø., Arias, C. A., Singh, K. V., Murray, B. E., & Monk, J. M. (2020) · Microbiology Resource Announcements · doi:10.1128/mra.01515-19 · Cited by 3
Staphylococcus aureus bacteremia in a tertiary care hospital in India
Abdulsalam, M. S., Gopalakrishnan, R., Suresh Kumar, D., Thirunarayan, M., Venkatesh, S., & Ramakrishnan, B. (2018) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2018.03.004 · Cited by 2
Doub, J. B. (2020) · IDCases · doi:10.1016/j.idcr.2020.e01023 · Cited by 2
Clinical pharmacology of cefazolin
Pacifici, G. M. (2022) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_31_22 · Cited by 2
Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C β-Lactamases
George, C. R. R., Lahra, M. M., Nguyen, T., & Gatus, B. J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00220-23 · Cited by 3
Smelter, A. A., Frei, C. R., & Smelter, D. F. (2025) · ASM Case Reports · doi:10.1128/asmcr.00114-24 · Cited by 2
Onita, T., Ikawa, K., Ishihara, N., Tamaki, H., & Yano, T. (2025) · Antibiotics · doi:10.3390/antibiotics14101008 · Cited by 2
Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses
Bremmer, D. N., Balada-Llasat, J.-M., Goff, D. A., & Bauer, K. A. A. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.02.019 · Cited by 2
Metadata
- Authors
- Li, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-09
- Volume
- 58
- Issue
- 9
- Pages
- 5117-5124
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC4135867
- OpenAlex
- W2168149280
- Semantic Scholar
- dd246878d23fb3747e00201e22c14f020dad911e
- Cited by
- 117
- References
- 25
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 3 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 10 · 2019: 10 · 2018: 23 · 2017: 13 · 2016: 10 · 2015: 6 · 2014: 1
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Texas ScholarWorks (Texas Digital Library) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- cefazolin, oxacillin, methicillin-susceptible Staphylococcus aureus, complicated bacteremia, antibiotic treatment failure, adverse drug reactions, bone and joint infections, endovascular infection, duration of bacteremia, surgical treatment, antibiotic selection
- MeSH terms
- Anti-Bacterial Agents, Cefazolin, Female, Humans, Male, Methicillin, Microbial Sensitivity Tests, Middle Aged, Oxacillin, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Bacteremia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.